Detalhe da pesquisa
1.
Influenza T-cell epitope-loaded virosomes adjuvanted with CpG as a potential influenza vaccine.
Pharm Res
; 32(4): 1505-15, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25344321
2.
Stabilised aluminium phosphate nanoparticles used as vaccine adjuvant.
Colloids Surf B Biointerfaces
; 181: 648-656, 2019 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31212137
3.
Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8+ T Cell Epitopes.
Front Immunol
; 9: 525, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29593747
4.
A Design of Experiment approach to predict product and process parameters for a spray dried influenza vaccine.
Int J Pharm
; 511(2): 1098-111, 2016 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27523619
5.
Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach.
Eur J Pharm Biopharm
; 94: 427-35, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26144666
6.
Solid bioneedle-delivered influenza vaccines are highly thermostable and induce both humoral and cellular immune responses.
PLoS One
; 9(3): e92806, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24671048